1. The safety of percutaneous renal biopsy for acute kidney injury in metastatic renal cell cancer patients with reduced nephron massTomaž Milanez, Vinay Srinivasan, Vladimir Premru, Miha Arnol, Janja Ocvirk, Edgar A. Jaimes, 2025, original scientific article Abstract: Background: Percutaneous renal biopsy (PRB) provides valuable information to guide treatment decisions in patients with metastatic renal cell carcinoma (mRCC) who develop acute kidney injury (AKI) after systemic anticancer therapy (SACT). The rising incidence of renal cell carcinoma (RCC) and the substantial impact of SACT on overall survival suggest a higher prevalence of RCC patients with reduced nephron mass and a solitary kidney (SK) requiring PRB for AKI. However, safety data on SK biopsies are scarce, and the potential for dialysis-requiring complications may deter clinicians. Methods: This retrospective case series reports the safety of 13 PRBs in 12 mRCC patients with reduced nephron mass who developed AKI during SACT as well as six PRBs in six patients with metastatic solid malignancies and AKI, which developed during SACT. Results: Eleven biopsies in mRCC patients and five biopsies in patients with metastatic solid malignancies were uneventful. One patient with mRCC experienced a major bleeding event due to an arteriovenous (AV) fistula seven days post-procedure, while another mRCC patient developed macrohematuria within 24 hours. In the group of patients with metastatic solid malignancies, one patient experienced a small perinephric hematoma during the observational period. Despite the small sample size, individual chart reviews and direct management of adverse events allowed assessment of the association between biopsy and complications.
Keywords: percutaneous renal biopsy, renal cell cancer, internal oncology
Published in DiRROS: 13.04.2026; Views: 95; Downloads: 44
 Full text (452,76 KB)
This document has many files! More... |
2. |
3. Ell quantity in nodal T-follicular helper cell lymphomas and peripheral T-cell lymphomas, not otherwise specified and its correlation with overall survivalEva Erzar, Alexandar Tzankov, Janja Ocvirk, Biljana Grčar-Kuzmanov, Lučka Boltežar, Veronika Kloboves-Prevodnik, Gorana Gašljević, 2024, published scientific conference contribution Published in DiRROS: 25.02.2026; Views: 276; Downloads: 77
Full text (119,42 KB) |
4. Nodal T-follicular helper cell lymphomas and peripheral T-cell lymphomas, not otherwise specified in Slovenian patients : mutational landscape, clinicopathological characteristics and outcomesEva Erzar, Vanesa-Sindi Ivanova, Stefan Dirnhofer, Lučka Boltežar, Janja Ocvirk, Veronika Kloboves-Prevodnik, Alexandar Tzankov, Gorana Gašljević, 2024, published scientific conference contribution Published in DiRROS: 25.02.2026; Views: 242; Downloads: 71
Full text (118,24 KB) |
5. |
6. |
7. |
8. |
9. Simpozij - Melanom in nemelanomski kožni raki : zbornik povzetkov2025, not set Keywords: kožni tumorji, kožni melanom, kirurško zdravljenje, sistemsko zdravljenje, registri, biološki označevalci, elektrokemoterapija, radioterapija, nuklearna medicina, zborniki, ktronske knjige
Published in DiRROS: 17.12.2025; Views: 587; Downloads: 212
Full text (547,84 KB)
This document has many files! More... |
10. |
